Latest News and Press Releases

EpiCept Provides Update on Ceplene® Manufacturing at Ben Venue Laboratories Supplies Available for Patients in European Union TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--...

EpiCept to Present at the 22nd Annual Wall Street Institutional Investor Conference   TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq...

EpiCept to Present at the NYSSA Biotech and Specialty Pharma Conference   TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX...

EpiCept Corporation Reports Third Quarter 2011 Operating and Financial Results Conference Call Begins at 9:00 A.M. Eastern Time TARRYTOWN, N.Y.--(BUSINESS...

EpiCept to Report Third Quarter 2011 Operating and Financial Results on November 8th, 2011   TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation...

EpiCept Common Stock to Begin Trading on OTCQX®, The Highest Tier of the OTC Market, on September 19, 2011 Withdraws from Nasdaq; Avoids Reverse Split TARRYTOWN, N.Y.--(BUSINESS...

EpiCept Corporation Provides U.S. Regulatory Update for Ceplene® Clinical Development   TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation...

EpiCept Common Stock Approved for Primary Listing on OMX Stockholm Exchange   TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX...

EpiCept to Present at Two Upcoming Industry Conferences   TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...

EpiCept Corporation Reports Second Quarter 2011 Financial Results and Provides Business Update Conference Call Begins at 9:00 A.M. Eastern Time Today TARRYTOWN, N.Y.--(BUSINESS...